{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:27:05Z","timestamp":1790908025665,"version":"4.1.0"},"reference-count":26,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Oncolytic viruses that can destroy cancer cells have been engineered in a variety of ways with the aim of improving their selectivity and efficacy. Here, we review data from clinical investigations of these virotherapeutic agents, specifically those that have shown systemic efficacy: vaccinia, measles, mumps, viruses, Newcastle disease virus, and reovirus. Further directions for optimizing i.v. delivery and efficacy are discussed. [Cancer Res 2007;67(2):429\u201332]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-2871","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T16:53:23Z","timestamp":1169139203000},"page":"429-432","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Systemic Efficacy with Oncolytic Virus Therapeutics: Clinical Proof-of-Concept and Future Directions"],"prefix":"10.1158","volume":"67","author":[{"given":"Ta-Chiang","family":"Liu","sequence":"first","affiliation":[{"name":"1Brain Tumor Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kirn","sequence":"additional","affiliation":[{"name":"2JENNEREX Biotherapeutics, Inc., San Francisco, California; and"},{"name":"3Department of Clinical Pharmacology, University of Oxford Medical School, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"2022061623240063700_B1","doi-asserted-by":"crossref","unstructured":"Bierman HR, Crile DM, Dod KS, et al. Remissions in leukemia of childhood following acute infectious disease: staphylococcus and streptococcus, varicella, and feline panleukopenia. Cancer\u20081953; 6: 591\u2013605.","DOI":"10.1002\/1097-0142(195305)6:3<591::AID-CNCR2820060317>3.0.CO;2-M"},{"key":"2022061623240063700_B2","doi-asserted-by":"crossref","unstructured":"Pasquinucci G. Possible effect of measles on leukaemia. Lancet\u20081971; 1: 136.","DOI":"10.1016\/S0140-6736(71)90869-5"},{"key":"2022061623240063700_B3","doi-asserted-by":"crossref","unstructured":"Bluming AZ, Ziegler JL. Regression of Burkitt's lymphoma in association with measles infection. Lancet\u20081971; 2: 105\u20136.","DOI":"10.1016\/S0140-6736(71)92086-1"},{"key":"2022061623240063700_B4","doi-asserted-by":"crossref","unstructured":"Taqi AM, Abdurrahman MB, Yakubu AM, Fleming AF. Regression of Hodgkin's disease after measles. Lancet\u20081981; 1: 1112.","DOI":"10.1016\/S0140-6736(81)92286-8"},{"key":"2022061623240063700_B5","doi-asserted-by":"crossref","unstructured":"Hansen RM, Libnoch JA. Remission of chronic lymphocytic leukemia after smallpox vaccination. Arch Intern Med\u20081978; 138: 1137\u20138.","DOI":"10.1001\/archinte.138.7.1137"},{"key":"2022061623240063700_B6","doi-asserted-by":"crossref","unstructured":"Greentree LB. Hodgkin's disease: therapeutic role of measles vaccine. Am J Med\u20081983; 75: 928.","DOI":"10.1016\/0002-9343(83)90865-3"},{"key":"2022061623240063700_B7","doi-asserted-by":"crossref","unstructured":"Schattner A. Therapeutic role of measles vaccine in Hodgkin's disease. Lancet\u20081984; 1: 171.","DOI":"10.1016\/S0140-6736(84)90112-0"},{"key":"2022061623240063700_B8","doi-asserted-by":"crossref","unstructured":"Southam CM, Moore AE. Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus. Cancer\u20081952; 5: 1025\u201334.","DOI":"10.1002\/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q"},{"key":"2022061623240063700_B9","doi-asserted-by":"crossref","unstructured":"Milton GW, Brown MM. The limited role of attenuated smallpox virus in the management of advanced malignant melanoma. Aust N Z J Surg\u20081966; 35: 286\u201390.","DOI":"10.1111\/j.1445-2197.1966.tb03889.x"},{"key":"2022061623240063700_B10","doi-asserted-by":"crossref","unstructured":"Hunter-Craig I, Newton KA, Westbury G, Lacey BW. Use of vaccinia virus in the treatment of metastatic malignant melanoma. Br Med J\u20081970; 2: 512\u20135.","DOI":"10.1136\/bmj.2.5708.512"},{"key":"2022061623240063700_B11","doi-asserted-by":"crossref","unstructured":"Arakawa S, Jr., Hamami G, Umezu K, Kamidono S, Ishigami J, Arakawa S. Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. Report on two cases. J Cancer Res Clin Oncol\u20081987; 113: 95\u20138.","DOI":"10.1007\/BF00389974"},{"key":"2022061623240063700_B12","doi-asserted-by":"crossref","unstructured":"Roenigk HH, Jr., Deodhar S, St Jacques R, Burdick K. Immunotherapy of malignant melanoma with vaccinia virus. Arch Dermatol\u20081974; 109: 668\u201373.","DOI":"10.1001\/archderm.109.5.668"},{"key":"2022061623240063700_B13","unstructured":"Kawa A, Arakawa S. The effect of attenuated vaccinia virus AS strain on multiple myeloma; a case report. Jpn J Exp Med\u20081987; 57: 79\u201381."},{"key":"2022061623240063700_B14","doi-asserted-by":"crossref","unstructured":"Asada T. Treatment of human cancer with mumps virus. Cancer\u20081974; 34: 1907\u201328.","DOI":"10.1002\/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4"},{"key":"2022061623240063700_B15","unstructured":"Okuno Y, Asada T, Yamanishi K, et al. Studies on the use of mumps virus for treatment of human cancer. Biken J\u20081978; 21: 37\u201349."},{"key":"2022061623240063700_B16","doi-asserted-by":"crossref","unstructured":"Wheelock EF, Dingle JH. Observations on the repeated administration of viruses to a patient with acute leukemia. A preliminary report. N Engl J Med\u20081964; 271: 645\u201351.","DOI":"10.1056\/NEJM196409242711302"},{"key":"2022061623240063700_B17","doi-asserted-by":"crossref","unstructured":"Csatary LK, Gosztonyi G, Szeberenyi J, et al. MTH-68\/H oncolytic viral treatment in human high-grade gliomas. J Neurooncol\u20082004; 67: 83\u201393.","DOI":"10.1023\/B:NEON.0000021735.85511.05"},{"key":"2022061623240063700_B18","doi-asserted-by":"crossref","unstructured":"Mastrangelo MJ, Maguire HC, Jr., Eisenlohr LC, et al. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther\u20081999; 6: 409\u201322.","DOI":"10.1038\/sj.cgt.7700066"},{"key":"2022061623240063700_B19","doi-asserted-by":"crossref","unstructured":"Aghi M, Martuza RL. Oncolytic viral therapies: the clinical experience. Oncogene\u20082005; 24: 7802\u201316.","DOI":"10.1038\/sj.onc.1209037"},{"key":"2022061623240063700_B20","doi-asserted-by":"crossref","unstructured":"Pecora AL, Rizvi N, Cohen GI, et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol\u20082002; 20: 2251\u201366.","DOI":"10.1200\/JCO.2002.08.042"},{"key":"2022061623240063700_B21","unstructured":"Lorence RM, Pecora AL, Major PP, et al. Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Curr Opin Mol Ther\u20082003; 5: 618\u201324."},{"key":"2022061623240063700_B22","doi-asserted-by":"crossref","unstructured":"reeman AI, Zakay-Rones Z, Gomori JM, et al. Phase I\/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther\u20082006; 13: 221\u20138.","DOI":"10.1016\/j.ymthe.2005.08.016"},{"key":"2022061623240063700_B23","doi-asserted-by":"crossref","unstructured":"Nemunaitis J, Cunningham C, Buchanan A, et al. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther\u20082001; 8: 746\u201359.","DOI":"10.1038\/sj.gt.3301424"},{"key":"2022061623240063700_B24","doi-asserted-by":"crossref","unstructured":"Hamid O, Varterasian ML, Wadler S, et al. Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer. J Clin Oncol\u20082003; 21: 1498\u2013504.","DOI":"10.1200\/JCO.2003.09.114"},{"key":"2022061623240063700_B25","doi-asserted-by":"crossref","unstructured":"Small EJ, Carducci MA, Burke JM, et al. A Phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther\u20082006; 14: 107\u201317.","DOI":"10.1016\/j.ymthe.2006.02.011"},{"key":"2022061623240063700_B26","doi-asserted-by":"crossref","unstructured":"Garber K. China approves world's first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst\u20082006; 98: 298\u2013300.","DOI":"10.1093\/jnci\/djj111"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/429\/2866481\/429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/429\/2866481\/429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:29:30Z","timestamp":1655436570000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/2\/429\/533425\/Systemic-Efficacy-with-Oncolytic-Virus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,15]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,1,18]]},"published-print":{"date-parts":[[2007,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-2871","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,15]]}}}